Literature DB >> 1331763

Characterization of homologous 5-hydroxytryptamine4 receptor desensitization in colliculi neurons.

H Ansanay1, M Sebben, J Bockaert, A Dumuis.   

Abstract

Exposure of mouse colliculi neurons to selective 5-hydroxytryptamine (5-HT)4 agonists was accompanied by a rapid desensitization of the receptor-stimulated adenylyl cyclase response. Half-maximal desensitization occurred after 2 min. Only exposure of neurons to selective 5-HT4 agonists led to a potent desensitization of the 5-HT4-mediated response. Neurons exposed to other agents, like isoproterenol, vasoactive intestinal peptide, or forskolin, that increase cAMP levels did not undergo any desensitization of 5-HT4 receptors. Activation of protein kinase A with either 8-bromo-cAMP or dibutyryl-cAMP or application of inhibitors of protein kinase A-dependent phosphorylation did not change the rate of 5-HT4-induced desensitization. No shift to lower potency of 5-HT4 agonists in the concentration-response curve was observed. These results suggest that 5-HT4 receptor agonists induced homologous but not cAMP-mediated heterologous desensitization. A good correlation was found between the affinities of nine 5-HT4 agonists and their abilities to desensitize the adenylyl cyclase response. This may indicate that homologous desensitization is a function of the mean occupancy time of the receptors by agonists. When permeabilized neurons were loaded with heparin, an inhibitor of the beta-adrenergic receptor kinase (beta ARK), 5-HT4 receptor desensitization was reduced by 30-40%. Interestingly, Zn2+, an other inhibitor of beta ARK, totally prevented 5-HT4-induced desensitization. Pretreatment of neurons with concanavalin A, reported to inhibit sequestration of beta-adrenergic receptors from the cell surface, reduced the desensitization process by 70%. These data suggest that both sequestration and phosphorylation by beta ARK, or another specific agonist-dependent receptor kinase, are involved in homologous desensitization of 5-HT4 receptors coupled to adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331763

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.

Authors:  J H De Maeyer; J A J Schuurkes; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

2.  Changes in sensitivity of 5-HT receptor mediated functional responses in the rat oesophagus, fundus and jejunum following chronic infusion with 5-hydroxytryptamine.

Authors:  P G McLean; I M Coupar; P Molenaar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

3.  Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development.

Authors:  Joris H De Maeyer; Roel Straetemans; Jan A J Schuurkes; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  Desensitization of the human 5-HT4 receptor in isolated atria of transgenic mice.

Authors:  Ulrich Gergs; Julia Fritsche; Stephanie Fabian; Josepha Christ; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-08       Impact factor: 3.000

5.  Ability of 5-HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo.

Authors:  L J Steward; J Ge; R L Stowe; D C Brown; R K Bruton; P R Stokes; N M Barnes
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic beta-adrenoceptor blockade.

Authors:  A J Kaumann; L Sanders
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

7.  Characterization of human 5-HT4(d) receptor desensitization in CHO cells.

Authors:  Jeanne Mialet; Rodolphe Fischmeister; Frank Lezoualc'h
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

8.  Donecopride, a Swiss army knife with potential against Alzheimer's disease.

Authors:  Christophe Rochais; Cédric Lecoutey; Katia Hamidouche; Patrizia Giannoni; Florence Gaven; Eleazere Cem; Serge Mignani; Kevin Baranger; Thomas Freret; Joël Bockaert; Santiago Rivera; Michel Boulouard; Patrick Dallemagne; Sylvie Claeysen
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

9.  Cloning and functional expression of an Aplysia 5-HT receptor negatively coupled to adenylate cyclase.

Authors:  A Angers; M V Storozhuk; T Duchaîne; V F Castellucci; L DesGroseillers
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

10.  Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease.

Authors:  Patrizia Giannoni; Florence Gaven; Dimitri de Bundel; Kevin Baranger; Evelyne Marchetti-Gauthier; François S Roman; Emmanuel Valjent; Philippe Marin; Joël Bockaert; Santiago Rivera; Sylvie Claeysen
Journal:  Front Aging Neurosci       Date:  2013-12-24       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.